Martini Gregory S. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Martini Gregory S. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $83K.

Profile

Martini Gregory S.

Gregory S. Martini is the Chief Financial Officer of Ironwood Pharmaceuticals Inc, a company focused on developing therapies for gastrointestinal and other diseases. He has been involved in the financial management of the company, contributing to its strategic direction.

RoleInsider
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-03-12IRWDIRONWOOD PHARMACEUTICALS INCA — Grant or award136.6K$0.00
2026-02-25IRWDIRONWOOD PHARMACEUTICALS INCS — Open-market sale11.5K$3.66$42K
2026-02-25IRWDIRONWOOD PHARMACEUTICALS INCS — Open-market sale10.5K$3.81$40K
2025-08-11IRWDIRONWOOD PHARMACEUTICALS INCS — Open-market sale1.3K$0.84$1K

Companies — Last 90 Days

Frequently Asked Questions

Who is Martini Gregory S.?

Gregory S. Martini is the Chief Financial Officer of Ironwood Pharmaceuticals Inc, a company focused on developing therapies for gastrointestinal and other diseases. He has been involved in the financial management of the company, contributing to its strategic direction.…

How many SEC Form 4 filings has Martini Gregory S. submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Martini Gregory S. been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($83K) across all tracked filings.

Where can I see all of Martini Gregory S.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Martini Gregory S. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.